The selected cell line's mutations represented melanoma - eight CDX samples originated from BRAF mutant melanoma, SK-MEL-2 harbored an activating Q61R NRAS mutation and MeWo carried multiple NF1 inactivating mutations (Figure 1A and Supplementary Table S1). The gene discussed is BRAF; the disease is melanoma.